{"id":5816,"date":"2022-05-16T18:06:45","date_gmt":"2022-05-16T18:06:45","guid":{"rendered":"https:\/\/www.sicklecelldisease.org\/?p=5816"},"modified":"2022-05-16T18:06:45","modified_gmt":"2022-05-16T18:06:45","slug":"scdaa-releases-comments-on-the-cdcs-opioid-guidelines","status":"publish","type":"post","link":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/","title":{"rendered":"SCDAA Releases Comments on the CDC&#8217;s Opioid Guidelines"},"content":{"rendered":"<p><span>The Centers for Disease Control and Prevention (CDC) recently drafted an update to its guidelines for prescribing opioids and reached out to SCDAA for feedback. After decades of misinformation, poor guidance and systemic racism, which have created barriers for SCD patients to receive adequate care for pain, we urge the CDC to go further to support the sickle cell community&#8217;s needs for pain management. <a href=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2022\/04\/SCDAA-Opioid-Guidelines.pdf\">Read the full statement.<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Centers for Disease Control and Prevention (CDC) recently drafted an update to its guidelines for prescribing opioids and reached out to SCDAA for feedback. After decades of misinformation, poor guidance and systemic racism, which have created barriers for SCD patients to receive adequate care for pain, we urge the CDC to go further to [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-5816","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SCDAA Releases Comments on the CDC&#039;s Opioid Guidelines - Sickle Cell Disease Association of America Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCDAA Releases Comments on the CDC&#039;s Opioid Guidelines - Sickle Cell Disease Association of America Inc.\" \/>\n<meta property=\"og:description\" content=\"The Centers for Disease Control and Prevention (CDC) recently drafted an update to its guidelines for prescribing opioids and reached out to SCDAA for feedback. After decades of misinformation, poor guidance and systemic racism, which have created barriers for SCD patients to receive adequate care for pain, we urge the CDC to go further to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"Sickle Cell Disease Association of America Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-16T18:06:45+00:00\" \/>\n<meta name=\"author\" content=\"Emma Day\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emma Day\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/\",\"url\":\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/\",\"name\":\"SCDAA Releases Comments on the CDC's Opioid Guidelines - Sickle Cell Disease Association of America Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/#website\"},\"datePublished\":\"2022-05-16T18:06:45+00:00\",\"dateModified\":\"2022-05-16T18:06:45+00:00\",\"author\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sicklecelldisease.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCDAA Releases Comments on the CDC&#8217;s Opioid Guidelines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#website\",\"url\":\"https:\/\/www.sicklecelldisease.org\/\",\"name\":\"Sickle Cell Disease Association of America Inc.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sicklecelldisease.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3\",\"name\":\"Emma Day\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g\",\"caption\":\"Emma Day\"},\"url\":\"https:\/\/www.sicklecelldisease.org\/author\/emma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCDAA Releases Comments on the CDC's Opioid Guidelines - Sickle Cell Disease Association of America Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/","og_locale":"en_US","og_type":"article","og_title":"SCDAA Releases Comments on the CDC's Opioid Guidelines - Sickle Cell Disease Association of America Inc.","og_description":"The Centers for Disease Control and Prevention (CDC) recently drafted an update to its guidelines for prescribing opioids and reached out to SCDAA for feedback. After decades of misinformation, poor guidance and systemic racism, which have created barriers for SCD patients to receive adequate care for pain, we urge the CDC to go further to [&hellip;]","og_url":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/","og_site_name":"Sickle Cell Disease Association of America Inc.","article_published_time":"2022-05-16T18:06:45+00:00","author":"Emma Day","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Emma Day"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/","url":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/","name":"SCDAA Releases Comments on the CDC's Opioid Guidelines - Sickle Cell Disease Association of America Inc.","isPartOf":{"@id":"https:\/\/www.sicklecelldisease.org\/#website"},"datePublished":"2022-05-16T18:06:45+00:00","dateModified":"2022-05-16T18:06:45+00:00","author":{"@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3"},"breadcrumb":{"@id":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sicklecelldisease.org\/2022\/05\/16\/scdaa-releases-comments-on-the-cdcs-opioid-guidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sicklecelldisease.org\/"},{"@type":"ListItem","position":2,"name":"SCDAA Releases Comments on the CDC&#8217;s Opioid Guidelines"}]},{"@type":"WebSite","@id":"https:\/\/www.sicklecelldisease.org\/#website","url":"https:\/\/www.sicklecelldisease.org\/","name":"Sickle Cell Disease Association of America Inc.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sicklecelldisease.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3","name":"Emma Day","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g","caption":"Emma Day"},"url":"https:\/\/www.sicklecelldisease.org\/author\/emma\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/5816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/comments?post=5816"}],"version-history":[{"count":1,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/5816\/revisions"}],"predecessor-version":[{"id":5817,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/5816\/revisions\/5817"}],"wp:attachment":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/media?parent=5816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/categories?post=5816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/tags?post=5816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}